ArticleFrontiers in pharmacology2023

Design, synthesis, and evaluation of 4-(3-(3,5-dimethylisoxazol-4-yl)benzyl)phthalazin-1(2H)-one derivatives: potent BRD4 inhibitors with anti-breast cancer activity.

Yingpeng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.